← SynDRA
LEVOSALBUTAMOL
SynDRA canonical compound SYN0003073 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ADRB2 |
|---|
| Mechanism of action | Adrenergic receptor agonist |
|---|
| Indication | bronchospasm |
|---|
| Disease area | pulmonary |
|---|
All known targets
Mechanisms of action (all sources)
- Adrenergic receptor agonist
- ADRB2 AGONIST
- Beta-2 adrenergic receptor agonist
- ADRB2 ANTAGONIST
Drug classes
- Adrenergic beta2-Agonists
- beta2-Adrenergic Agonist
Cross-references
Synonyms
- xopenex
- levalbuterol HCl
- (-)-Salbutamol
- (R)-Salbutamol
- levalbuterol
- levalbuterol hydrochloride
- levalbuterol tartrate
- Albuterol (r)-form
- Levalbuterol
- R-salbutamol
- ASF-1096
- (R)-salbutamol
- Xopenex
- R-Salbutamol
- R-Albuterol
- (r)-(-)-salbutamol
- UNII-EDN2NBH5SS
- 4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol
- EDN2NBH5SS
- CHEBI:8746
- Levosalbutamol (INN)
- Levosalbutamol [INN]
- (R)-albuterol
- m-Xylene-alpha,alpha'-diol, alpha(sup 1)-((tert-butylamino)methyl)-4-hydroxy-, (R)-(-)-
- (-)-alpha(sup 1)-(((1,1-Dimethylethyl)amino)methyl)-4-hydroxy-1,3-benzenedimethanol
- R-salbutamol sulphate
- Albuterol (r)-
- (-)-Albuterol
- levosalbutamolum
- Levalbuterol Inhalation
- RefChem:56698
- Hydrochloride, Levalbuterol
- Hydrochloride, Levosalbutamol
- DTXCID40110455
- levalbuterol inhalation 0.31mg/3mL
- levalbuterol inhalation 0.63mg/3mL
- levalbuterol inhalation 1.25mg/3mL
- (-)-Albuterol sulfate (1
Reported adverse events
- Anxiety
- Back pain
- Cough
- Dizziness
- Dyspepsia
- Hypertonia
- Migraine
- Nervousness
- Pain
- Rhinitis
- Sinusitis
- Tachycardia
Look up LEVOSALBUTAMOL in the interactive SynDRA portal →